Trial Profile
Evaluation of survival and dosing patterns of carfilzomib among patients with multiple myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jan 2016
Price :
$35
*
At a glance
- Drugs Carfilzomib (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 22 Jan 2016 New trial record
- 08 Dec 2015 Results of retrospective study presented at the 57th Annual Meeting and Exposition of the American Society of Hematology